News & Perspective

Nov 17, 2006

Nov 17, 2006

FluMist called safe, effective for kids with asthma

(CIDRAP News) – For children and adolescents with asthma, the intranasal influenza vaccine FluMist was as safe as and more effective than an injectable vaccine in a phase 3 trial of young people aged 6 to about 17 years.

The study, which involved 2,229 children at 145 sites in 12 European countries and Israel, was published in the October issue of The Pediatric Infectious Disease Journal.